Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
GlobeNewswire, Inc.
Recommendation based on results from Phase 3 RASolute 302 trial, which demonstrated a 60% reduction in risk of death compared with chemotherapy in the overall study population with statistically significant and clinically meaningful improvements...
European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
GlobeNewswire, Inc.
BARCELONA, Spain and DÜSSELDORF, Germany, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Neuraxpharm Group and Minoryx Therapeutics today announce that the European Commission (EC) has granted marketing authorisation under exceptional circumstances for...
Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
GlobeNewswire, Inc.
Press release – No. 16 / 2026 Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome The CHMP of the European Medicines Agency has recommended the approval of Zeydovio™ (glepaglutide)...
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
GlobeNewswire, Inc.
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing.
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
GlobeNewswire, Inc.
- Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe - - Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and TANDEM data - - European...
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma
GlobeNewswire, Inc.
BRUSSELS, July 01, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company designed to address rare and urgent conditions, today announced that it has completed the acquisition of exclusive development and...
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
GlobeNewswire, Inc.
BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
GlobeNewswire, Inc.
Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients.
New Memoranda pave the way for €50 million in investments in local development and public health
Government of Slovenia
SLOVENIA, May 18 - The Memoranda were signed by His Excellency Vegard Kaale, Ambassador of the Kingdom of Norway, Her Excellency Helga Hauksdóttir, Ambassador of Iceland, representing the Donor States, i.e., the Kingdom of Norway, the Principality...
4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama as Venture Partner
GlobeNewswire, Inc.
Thera Liechtenstein brings extensive biotech investment and company‑building experience to new role as Partner at 4BIO Capital Tetsu Maruyama, former Head of Drug Discovery at Takeda Pharmaceuticals, appointed as Venture Partner London, United...
Slovenia’s efforts to promote the rights of older persons at UNHRC 63rd regular session
Government of Slovenia
SLOVENIA, October 7 - Of particular significance for Slovenia at the session were the first appearance of Prof. Zvezdan Pirtošek in his capacity as Independent Expert on the enjoyment of all human rights by older persons, the increased focus on...
A European Gateway to Commercial Space is established in Dübendorf
EIN Presswire
Zurich Gains Direct Access to the International Space Station and the Starlab Space Station ZURICH, ZURICH, SWITZERLAND, September 7, 2026 /EINPresswire.com/ -- The Center for Space and Aviation Switzerland and Liechtenstein (CSA) is bringing...
8th Swiss Parabolic Flight Campaign: A Clear Shift Toward Commercial Space
EIN Presswire
ZURICH, ZURICH, SWITZERLAND, September 7, 2026 /EINPresswire.com/ -- The 8th Swiss Parabolic Flight Campaign, organized by the Center for Space and Aviation Switzerland and Liechtenstein (CSA), take place from 7 to 11 September 2026 at the...
Obyte Introduces Coop: A Decentralized Community System to Reward Meaningful Contributions
EIN Presswire
Vote for contributors who help Obyte grow, receive votes for your own contributions, and earn daily emissions of COOP tokens in proportion to votes received VADUZ, LIECHTENSTEIN, August 14, 2026 /EINPresswire.com/ -- Obyte is glad to announce...
Prime Minister Carney advances collective security, climate, and peace priorities at the 81st United Nations General Assembly
Prime Minister of Canada
CANADA, September 23 - As the international order faces a rupture, Canada is stepping up to build and shape a new one. We are forging new partnerships, deepening our existing ones, and building a dense web of connections that will enable Canada to...
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
GlobeNewswire, Inc.
Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages More than five billion doses of the Pfizer-BioNTech COVID-19 vaccines...
Virella Files European Patent Application for Novel SIRT6 Small-Molecule Activators
EIN Presswire
Liechtenstein-based biotech company reports significant lifespan extension in C. elegans and advances toward preclinical development with CRO partners SCHAAN, LIECHTENSTEIN, April 3, 2026 /EINPresswire.com/ -- Virella Ltd, a European biotech...
European Commission’s Approval of CinnaGen’s Teriparatide Signals New Phase of Global Growth
EIN Presswire
The European Commission’s authorization of Zandoriah®, an osteoporosis medication, marks a significant step in CinnaGen’s journey of international expansion DUBAI, DUBAI, UNITED ARAB EMIRATES, July 3, 2026 /EINPresswire.com/ -- July 02, 2026:...
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
GlobeNewswire, Inc.
New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda® (tovorafenib) represents a rare achievement that reinforces the urgent...
Remarks by Treasury Secretary Scott Bessent before the American Swiss Foundation
U.S. Department of the Treasury
Good afternoon.
Sign up for:
Health Monitor Liechtenstein
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.